1. Home
  2. JANX vs CMP Comparison

JANX vs CMP Comparison

Compare JANX & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

N/A

Current Price

$10.13

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Compass Minerals Intl Inc

CMP

Compass Minerals Intl Inc

N/A

Current Price

$19.64

Market Cap

999.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
JANX
CMP
Founded
2017
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Metals and Minerals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
999.1M
IPO Year
2021
2003

Fundamental Metrics

Financial Performance
Metric
JANX
CMP
Price
$10.13
$19.64
Analyst Decision
Buy
Buy
Analyst Count
18
4
Target Price
★ $33.14
$29.50
AVG Volume (30 Days)
★ 946.4K
342.1K
Earning Date
11-05-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.59
Revenue
★ $10,000,000.00
N/A
Revenue This Year
$174.21
$3.43
Revenue Next Year
N/A
$3.07
P/E Ratio
★ N/A
$33.95
Revenue Growth
N/A
★ N/A
52 Week Low
$10.16
$16.77
52 Week High
$35.34
$34.50

Technical Indicators

Market Signals
Indicator
JANX
CMP
Relative Strength Index (RSI) 25.34 26.12
Support Level N/A N/A
Resistance Level $14.47 $23.58
Average True Range (ATR) 1.16 0.68
MACD -0.48 -0.34
Stochastic Oscillator 0.33 4.33

Price Performance

Historical Comparison
JANX
CMP

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

About CMP Compass Minerals Intl Inc

Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.

Share on Social Networks: